SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-19-000059
Filing Date
2019-05-01
Accepted
2019-05-01 16:06:14
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20190331.htm   iXBRL 10-Q 907050
2 exhibit31-1q12019.htm EX-31.1 10005
3 exhibit31-2q12019.htm EX-31.2 10007
4 exhibit32-1q12019.htm EX-32.1 4835
5 exhibit32-2q12019.htm EX-32.2 4658
  Complete submission text file 0001125345-19-000059.txt   4225095

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20190331.xsd EX-101.SCH 33096
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20190331_cal.xml EX-101.CAL 56109
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20190331_def.xml EX-101.DEF 176140
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20190331_lab.xml EX-101.LAB 381657
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20190331_pre.xml EX-101.PRE 282117
11 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20190331_htm.xml XML 655704
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 19787452
SIC: 2834 Pharmaceutical Preparations